Alan Mark Goldberg

Affiliations

  • at Blueprint Medicines Corp (BPMC), 2024-06-14
  • at Glycomimetics Inc (GLYC), 2024-05-01
  • Director at Immunogen Inc. (IMGN), 2024-02-12
  • at Idera Pharmaceuticals Inc. (IDRA), 2022-06-27
  • Director at Audentes Therapeutics Inc. (BOLD), 2020-01-15
  • Director at Atyr Pharma Inc (LIFE), 2017-05-11
  • Evp, Medical & Reg. Strategy at Synageva Biopharma Corp (GEVA), 2014-09-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BPMC $59.98 5,000 $299,900.00 10,812 2022-03-03 Filing
IDRA $3.19 10,000 $31,897.00 10,000 2018-12-19 Filing
IMGN $5.76 30,000 $172,800.00 53,800 2018-11-06 Filing
IMGN $1.80 20,000 $36,000.00 23,800 2016-12-15 Filing
GLYC $4.77 10,397 $49,630.08 11,497 2016-03-04 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BPMC $125.00 5,455 $681,875.00 3,562 2020-12-24 Filing
BPMC $120.00 5,454 $654,480.00 3,562 2020-12-18 Filing
BPMC $115.00 5,455 $627,325.00 3,562 2020-12-11 Filing
BPMC $110.00 5,454 $599,940.00 3,562 2020-12-01 Filing
BPMC $105.00 5,455 $572,775.00 3,562 2020-10-19 Filing